Outcome of Board meeting for consideration and approval of Quarterly Unaudited Financial result for 30.06.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Archit Organosys approved the unaudited financial results for the quarter ended June 30, 2025. Revenue from operations rose to Rs. 3,319.56 lakhs from Rs. 2,700.44 lakhs in Q1 FY25, a growth of about 23% year-on-year. Net profit jumped to Rs. 203.59 lakhs from Rs. 100.54 lakhs, more than doubling year-on-year (around 102% growth), helped by a lower jump in raw material and trading purchase costs. EPS stood at Rs. 0.99 versus Rs. 0.49 in the same quarter last year. The statutory auditor (G. K. C S K & Co.) issued a clean limited review report with no qualifications. Separately, the Board appointed M/s Ankit Sethi & Associates as the new Secretarial Auditor for a 5-year term starting April 1, 2025, subject to shareholder approval.
Strong double-digit revenue growth and a doubling of quarterly profit indicate healthy operational momentum, which is positive for shareholders. No red flags were raised by auditors; the new Secretarial Auditor appointment is a routine compliance step and unlikely to affect the stock price.